EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia

Akash Maity iD, Rohit Kumar, Madhavi Dutta, Ansit Mishra, Jitendra Gawde, Jagruti Patil, Darshana Kadam, Sumeet Mirgh iD, Anant Gokarn, Hasmukh Jain, Lingaraj Nayak, Bhausaheb Bagal und 6 weitere

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2026. Verfasst von Akash Maity und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hasan Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Biomarkers, Tumor, Membrane Glycoproteins, Transforming Growth Factor beta. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research, Department of Atomic Energy, Govt. of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early diagnosis of acute promyelocytic leukemia (APL), driven by PML‐RARA oncoprotein, is vital for survival, as delays can cause fatal coagulopathy without prompt therapeutic intervention of all‐trans retinoic acid and arsenic trioxide. Although APL is diagnosed using microscopy, immunophenotyping, and FISH/PCR for PML‐RARA, morphological overlap with acute myeloid leukemia (AML) ‐M5 and AML‐M2 complicates identification. In resource‐limited settings, unavailability of real time ‐quantitiative PCR (RQ‐PCR) or delays in FISH/qualitative RT‐PCR results increase the risk of missed or late diagnosis with fatal outcomes. Podoplanin (PDPN), a glycoprotein overexpressed in APL cells, interacts with platelets to mediate thrombosis. We evaluated PDPN expression, regulation, and diagnostic potential in APL. PDPN mRNA (RQ‐PCR) and surface protein (flow cytometry) were significantly higher in APL than non‐APL AML ( p < 0.0001), consistent with TCGA‐LAML and BEATAML1.0 datasets. Sensitivity and specificity were 80.7% and 71.43% by RQ‐PCR, and 92.86% and 100% by flow cytometry, respectively. Chromatin immunoprecipitation followed by quantitative PCR (ChIP‐qPCR) and TGF‐ β1 stimulation confirmed SMAD binding and PDPN upregulation. Pharmacological inhibition of TGF‐β1 ligand using luspatercept reduced SMAD phosphorylation and PDPN expression, indicating TGF‐β/SMAD transcriptionally regulates PDPN. Additionally, ELISA‐based serum profiling showed significantly elevated TGF‐β1 levels in APL patients compared to non‐APL AML ( p < 0.0001). These findings identify PDPN overexpression as a downstream consequence of TGF‐β/SMAD signaling and highlight its potential as a diagnostic biomarker for APL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteBiomarkers, TumorMembrane GlycoproteinsTransforming Growth Factor betaHumansPodoplaninFemaleMaleMiddle AgedAdultSignal TransductionAgedCell Line, Tumor

Stichwörter der Autor:innen

RQ‐PCRTGF‐β1acute Promyelocytic Leukemia (APL)coagulopathyflow cytometrypodoplanin

Substanzen

PodoplaninPDPN protein, humanBiomarkers, TumorMembrane GlycoproteinsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Hasan Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Homi Bhabha National Institute (HBNI), Anushaktinagar, Mumbai, Maharashtra, India.
  • S.V.B. Cancer Research Laboratory, Mahamana Pandit Madanmohan Malaviya Cancer Centre (MPMMCC), Sundarpur, Varanasi, Uttar Pradesh, India.
  • Department of Statistics, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Hematopathology Laboratory, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India.

ORCID-Profile: Akash Maity, Sumeet Mirgh, P G Subramanian

Förderung

  • Indian Council of Medical Research
  • Department of Atomic Energy, Govt. of India

Zitieren

APA

Maity, A., Kumar, R., Dutta, M., Mishra, A., Gawde, J., Patil, J., Kadam, D., Mirgh, S., Gokarn, A., Jain, H., Nayak, L., Bagal, B., Punatar, S., Sengar, M., Khattry, N., Subramanian, P. G., Tembhare, P., & Hasan, S. K. (2026). TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70096

Vancouver

Maity A, Kumar R, Dutta M, Mishra A, Gawde J, Patil J, et al. TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70096

BibTeX
@article{Maity2026,
  author = {Maity, Akash and Kumar, Rohit and Dutta, Madhavi and Mishra, Ansit and Gawde, Jitendra and Patil, Jagruti and Kadam, Darshana and Mirgh, Sumeet and Gokarn, Anant and Jain, Hasmukh and Nayak, Lingaraj and Bagal, Bhausaheb and Punatar, Sachin and Sengar, Manju and Khattry, Navin and Subramanian, P G and Tembhare, Prashant and Hasan, Syed K},
  title = {TGFβ‐Mediated Overexpression of Podoplanin Serves as a Potential Diagnostic Biomarker in Acute Promyelocytic Leukemia},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70096}
}
Kostenlos starten →